Ansbert Gadicke Tcr2 Therapeutics Inc. (TCRR) insider trading activity

TCRR Quotes by TradingView

ANSBERT GADICKE Transaction History

Date Transaction Value Shares Traded Form
Jun 01 2023
SELL
Other acquisition or disposition
-
7,529,946
May 22 2023
SELL
Open market or private sale
$131,919 $1.88 p/Share
70,170
May 22 2023
BUY
Exercise of in-the-money or at-the-money derivatives securities
$131,919 $0.74 p/Share
178,269

Also insider at

ITOS
iTeos Therapeutics, Inc. Healthcare
> 10% Shareholder
RPTX
Repare Therapeutics Inc. Healthcare
> 10% Shareholder
CGEM
Cullinan Oncology, Inc. Healthcare
Director
ALVR
Allovir, Inc. Healthcare
Director
HOWL
Werewolf Therapeutics, Inc. Healthcare
> 10% Shareholder
HARP
Harpoon Therapeutics, Inc. Healthcare
> 10% Shareholder
ONCR
Oncorus, Inc. Healthcare
> 10% Shareholder
AG

Ansbert Gadicke

Director
Waltham, MA

Track Institutional and Insider Activities on TCRR

Follow TCR2 THERAPEUTICS INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells TCRR shares.

Notify only if

Insider Trading

Get notified when an Tcr2 Therapeutics Inc. insider buys or sells TCRR shares.

Notify only if

News

Receive news related to TCR2 THERAPEUTICS INC.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on TCRR